Localized leishmaniasis treated with intralesional meglumine antimoniate
03 medical and health sciences
Meglumine Antimoniate
Treatment Outcome
0302 clinical medicine
Antiprotozoal Agents
Humans
Leishmaniasis, Cutaneous
Injections, Intralesional
DOI:
10.1111/ddg.14165
Publication Date:
2020-07-13T05:44:04Z
AUTHORS (5)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....